홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Lithium Hydroxide → 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole

HRID 1614994
인쇄

반응식

HRID 1614994 반응식
Br[C:2]1[CH2:6][CH2:5][O:4][N:3]=1.COC(=O)[C:10]1[CH:15]=[C:14]([OH:16])[CH:13]=[N:12][CH:11]=1.[OH-].[Li+].O1CCCC1>O1CCCC1.O>[N:12]1[CH:11]=[CH:10][CH:15]=[C:14]([O:16][C:2]2[CH2:6][CH2:5][O:4][N:3]=2)[CH:13]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 3939Lithium HydroxideHCID 8028TetrahydrofuranHCID 354317Methyl 5-hydroxypyridine-3-carboxylateHCID 219834983-Bromo-4,5-dihydroisoxazole

생성물 1

HCID 668185323-(Pyridin-3-yloxy)-4,5-dihydroisoxazole

시약·촉매·용매 1

HCID 21881883Oxolane--water (1/1)
용매

실험 절차

The enantiomers of 3-(pyridin-3-yloxy)-4,5-dihydroisoxazole III-74a and III-74b were prepared in 2 steps according to the following procedures: racemic 3-bromo 4,5-dihydroisoxazole III-66 was reacted with 5-hydroxynicotinic acid methyl ester using Method 5. The resulting ester (1.0 equiv) was dissolved in 1:1 tetrahydrofuran/water (0.06 M) and lithium hydroxide (8.0 equiv) was added. The reaction was allowed to stir at room temperature for 1 h after which point the tetrahydrofuran was removed under a stream of nitrogen and the remaining solution was acidified to pH<2 with 1N HCl to provide the racemic desired acid III-74 as a white solid which was isolated via vacuum filtration. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=395.5 m/z. Activity: A

후처리

  1. additionwas added
  2. customwas removed under a stream of nitrogen

출처 및 근거

ORD 기록
ord-f320e0728bc8497ab9a6ddbc698743d9
출처 데이터셋
uspto-grants-2014_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08765735B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트